(Q39703837)

14 September 2017

title

Sirolimus and everolimus reduce albumin endocytosis in proximal tubule cells via an angiotensin II-dependent pathway (English)

1 reference

14 September 2017

1 reference

Melinda Oroszlán

1

1 reference

14 September 2017

Michael Bieri

2

1 reference

14 September 2017

Nathalie Ligeti

3

1 reference

14 September 2017

Anikó Farkas

4

1 reference

14 September 2017

Bernhard Meier

5

1 reference

14 September 2017

Hans-Peter Marti

6

1 reference

14 September 2017

Paul Mohacsi

7

1 reference

14 September 2017

language of work or name

1 reference

12 May 2010

1 reference

14 September 2017

published in

Transplant Immunology

1 reference

14 September 2017

volume

23

1 reference

14 September 2017

issue

3

1 reference

14 September 2017

page(s)

125-132

1 reference

Proliferation signal inhibitors in transplantation: questions at the cutting edge of everolimus therapy

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

Improving outcomes in heart transplantation: the potential of proliferation signal inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

Multidisciplinary insights on clinical guidance for the use of proliferation signal inhibitors in heart transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

Influence of sirolimus on proteinuria in de novo kidney transplantation with expanded criteria donors: comparison of two CNI-free protocols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

Proteinuria in transplant patients associated with sirolimus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

The mTOR inhibitor everolimus induces proteinuria and renal deterioration in the remnant kidney model in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

Everolimus versus mycophenolate mofetil in the prevention of rejection in de novo renal transplant recipients: a 3-year randomized, multicenter, phase III study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

Development of proteinuria after switch to sirolimus-based immunosuppression in long-term cardiac transplant patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

Post-rapamycin proteinuria: incidence, evolution, and therapeutic handling at a single center

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

Sirolimus-associated heavy proteinuria in a renal transplant recipient: evidence for a tubular mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

Differences in proteinuria and graft function in de novo sirolimus-based vs. calcineurin inhibitor-based immunosuppression in live donor kidney transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

Rapamycin-associated post-transplantation glomerulonephritis and its remission after reintroduction of calcineurin-inhibitor therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

Angiotensin II subtype 1 receptor blockers and renal function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

Effect of losartan treatment on the proteinuria in normotensive patients having proteinuria due to secondary amyloidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

Renal protective effects of blocking the intrarenal renin-angiotensin system: angiotensin II type I receptor antagonist compared with angiotensin-converting enzyme inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

Reduction of proteinuria with angiotensin receptor blockers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

Megalin- and cubilin-mediated endocytosis of protein-bound vitamins, lipids, and hormones in polarized epithelia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

Renal tubule albumin transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

Megalin and cubilin: multifunctional endocytic receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

Cubilin, a high-density lipoprotein receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

Megalin knockout mice as an animal model of low molecular weight proteinuria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

Mutations in LRP2, which encodes the multiligand receptor megalin, cause Donnai-Barrow and facio-oculo-acoustico-renal syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

Albumin transport and processing by the proximal tubule: physiology and pathophysiology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

Renal albumin absorption in physiology and pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

Megalin and cubilin--the story of two multipurpose receptors unfolds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

Modulation of the renin-angiotensin system in proteinuric renal disease: are there added benefits?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

Albumin endocytosis in proximal tubule cells is modulated by angiotensin II through an AT2 receptor-mediated protein kinase B activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

Regulation of megalin expression in cultured proximal tubule cells by angiotensin II type 1A receptor- and insulin-mediated signaling cross talk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

Angiotensin II blockade restores albumin reabsorption in the proximal tubules of diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

mTOR regulates expression of slit diaphragm proteins and cytoskeleton structure in podocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

Tubular toxicity in sirolimus- and cyclosporine-based transplant immunosuppression strategies: an ancillary study from a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

Sirolimus does not reduce receptor-mediated endocytosis of albumin in proximal tubule cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

Membrane receptors for endocytosis in the renal proximal tubule.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

Defective forebrain development in mice lacking gp330/megalin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

The roles of cubilin and megalin, two multiligand receptors, in proximal tubule function: possible implication in the progression of renal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

Molecular Dissection of the Intrinsic Factor-Vitamin B12Receptor, Cubilin, Discloses Regions Important for Membrane Association and Ligand Binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

Mutations in CUBN, encoding the intrinsic factor-vitamin B12 receptor, cubilin, cause hereditary megaloblastic anaemia 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

Transforming growth factor-beta1 reduces megalin- and cubilin-mediated endocytosis of albumin in proximal-tubule-derived opossum kidney cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

Sirolimus-associated proteinuria and renal dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.05.003

10.1016/J.TRIM.2010.05.003

7 January 2021

Identifiers

DOI

1 reference

14 September 2017

1 reference